Coreceptor usage of HIV-1 isolates representing different genetic subtypes obtained from pregnant Cameroonian women. European Network for In Utero Transmission of HIV-1.

In this study, coreceptor usage of HIV-1 other than subtype B in relation to HIV-1 transmission from mother to child was investigated. Repeated sampling of 42 HIV-1-seropositive, asymptomatic women in Cameroon during the second and third trimesters of pregnancy, at delivery, and 6 months postpartum were performed. Env subtyping was carried out from uncultured peripheral blood mononuclear cells (PBMCs) by heteroduplex mobility assay and, whenever necessary, by DNA sequencing. Virus isolates were tested for coreceptor usage on human cell lines-U87.CD4 and GHOST(3)-engineered to express stably CD4 and the chemokine receptors CCR1, CCR2b, CCR3, CCR5, or CXCR4, or the orphan receptors BOB/gpr15 or Bonzo/STRL33/TYMSTR. Transmission rate was 11.9%. Viruses were predominantly envelope subtype A and used CCR5 as coreceptor and, surprisingly, 4 of 28 (14.2%) isolates from mothers and 1 of 3 isolates from children used the orphan receptor Bonzo as well. In 2 transmitting mothers from whom sequential HIV-1 isolates were available, viral coreceptor usage evolved from CCR5 monotropic to CCR5/Bonzo dual tropic during pregnancy, and in 1 case transmission of this virus could be documented. Our data suggest that evolution of HIV-1 coreceptor usage to dual (or multi-) tropism may occur during pregnancy.

[1]  F. Barré-Sinoussi,et al.  An unusual HIV type 1 env sequence embedded in a mosaic virus from Cameroon: identification of a new env clade. European Network on the study of in utero transmission of HIV-1. , 1999, AIDS research and human retroviruses.

[2]  J. Carr,et al.  Characterization of subtype A HIV-1 from Africa by full genome sequencing. , 1999, AIDS.

[3]  J. Albert,et al.  Phenotypic characteristics of human immunodeficiency virus type 1 subtype C isolates of Ethiopian AIDS patients. , 1999, AIDS research and human retroviruses.

[4]  D. Gotte,et al.  Full genome sequences of human immunodeficiency virus type 1 subtypes G and A/G intersubtype recombinants. , 1998, Virology.

[5]  J. Albert,et al.  Differences in chemokine coreceptor usage between genetic subtypes of HIV-1. , 1998, Virology.

[6]  J. Goedert,et al.  The influence of pregnancy on human immunodeficiency virus type 1 infection: antepartum and postpartum changes in human immunodeficiency virus type 1 viral load. , 1998, American journal of obstetrics and gynecology.

[7]  E. Fenyö,et al.  In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression , 1997, Nature Medicine.

[8]  D. Littman,et al.  Expression cloning of new receptors used by simian and human immunodeficiency viruses , 1997, Nature.

[9]  K. Peden,et al.  A new SIV co-receptor, STRL33 , 1997, Nature.

[10]  C. Macken,et al.  Maternal HIV-1 viral load and vertical transmission of infection: The Ariel Project for the prevention of HIV transmission from mother to infant , 1997, Nature Medicine.

[11]  Anthony S. Fauci,et al.  Host factors and the pathogenesis of HIV-induced disease , 1996, Nature.

[12]  R. Doms,et al.  CD4-Independent Infection by HIV-2 Is Mediated by Fusin/CXCR4 , 1996, Cell.

[13]  D. Ho,et al.  HIV-1 subtype and second-receptor use , 1996, Nature.

[14]  C. Broder,et al.  CC CKR5: A RANTES, MIP-1α, MIP-1ॆ Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1 , 1996, Science.

[15]  Marc Parmentier,et al.  A Dual-Tropic Primary HIV-1 Isolate That Uses Fusin and the β-Chemokine Receptors CKR-5, CKR-3, and CKR-2b as Fusion Cofactors , 1996, Cell.

[16]  Ying Sun,et al.  The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 Isolates , 1996, Cell.

[17]  Virginia Litwin,et al.  HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5 , 1996, Nature.

[18]  Stephen C. Peiper,et al.  Identification of a major co-receptor for primary isolates of HIV-1 , 1996, Nature.

[19]  Paul E. Kennedy,et al.  HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor , 1996, Science.

[20]  H. Fleury,et al.  HIV type 1 Thai subtype E is predominant in South Vietnam. , 1996, AIDS research and human retroviruses.

[21]  N. Katopodis,et al.  Inhibition of acute in vivo human immunodeficiency virus infection by human interleukin 10 treatment of SCID mice implanted with human fetal thymus and liver. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[22]  O. Weislow,et al.  Maternal plasma human immunodeficiency virus type 1 RNA level: a determinant and projected threshold for mother-to-child transmission. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[23]  B. Korber,et al.  Standard conditions of virus isolation reveal biological variability of HIV type 1 in different regions of the world. WHO Network for HIV Isolation and Characterization. , 1994, AIDS research and human retroviruses.

[24]  P. Piot,et al.  Genotypic subtypes of HIV‐1 in Cameroon , 1994, AIDS.

[25]  J. Albert,et al.  Transmission of human immunodeficiency virus type 1 (HIV-1) from mother to child correlates with viral phenotype. , 1993, Virology.

[26]  P. Roques,et al.  Correlation between HIV provirus burden and in utero transmission , 1993, AIDS.

[27]  B. Larder,et al.  HIV‐1 biological phenotype and the development of zidovudine resistance in relation to disease progression in asymptomatic individuals during treatment , 1992, AIDS.

[28]  A. Ades,et al.  Risk of human immunodeficiency virus type 1 transmission through breastfeeding , 1992, The Lancet.

[29]  S. Lindgren,et al.  HIV and child-bearing: clinical outcome and aspects of mother-to-infant transmission. , 1991, AIDS.

[30]  J. Albert,et al.  Human immunodeficiency virus type 1 p24 production and antigenic variation in tissue culture of isolates with various growth characteristics , 1989, Journal of medical virology.

[31]  T. Quinn,et al.  Perinatal transmission of the human immunodeficiency virus type 1 to infants of seropositive women in Zaire. , 1989, The New England journal of medicine.